Please login to the form below

Not currently logged in
Email:
Password:

European Medicines Agency

This page shows the latest European Medicines Agency news and features for those working in and with pharma, biotech and healthcare.

Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s

Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s

Both the European Medicines Agency (EMA) and the World Health Organization (WHO) have since recommended the use of the AZ/Oxford vaccine in people over the age of 65.

Latest news

More from news
Approximately 8 fully matching, plus 819 partially matching documents found.

Latest Intelligence

  • Medicinal data – what’s next for IDMP? Medicinal data – what’s next for IDMP?

    The European Medicines Agency's (EMA) headquarters in Amsterdam. The global response to COVID-19 has shone a light on the broader potential for global data standards, including those defined via ... the International Organization for Standardization (ISO)

  • Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy

    Selumetinib, taken as a twice-daily oral capsule, sparked huge interest when it was granted Orphan Drug Designation by the US FDA in February 2018 and by the European Medicines Agency

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The European Medicines Agency (EMA) and The US Food and Drug Administration (FDA) have both provided guidance on how to manage clinical trials during the COVID-19 pandemic. ... The impact of the pandemic on European health systems and more broadly on

  • Novel endpoints in the digital age Novel endpoints in the digital age

    A European Medicines Agency spokesperson said: “Novel endpoints have the potential to be more precise and even more inclusive, meaning patients who would otherwise have been unwilling to enrol in a

  • Rethinking trials: the pros and cons of protocol amendments Rethinking trials: the pros and cons of protocol amendments

    The European Medicines Agency is not responsible for approving or overseeing the conduct of clinical trials, and therefore is not involved in clinical trial protocol amendments. ... However, when it comes to paediatric trials, the agency does get involved

More from intelligence
Approximately 0 fully matching, plus 51 partially matching documents found.

Latest appointments

  • New hires at EMA, Gilead and BeiGene New hires at EMA, Gilead and BeiGene

    European Medicines Agency (EMA). The European Medicines Agency (EMA) management board has nominated Emer Cooke (pictured above) as its new executive director. ... Cooke worked for the pharmaceutical unit of the European Commission from 1998 to 2002, and

  • Emotive grows medical writing capacity Emotive grows medical writing capacity

    Dr Silvana Bardelli and Dr Ann Gilliat join the agency. Healthcare Communications agency Emotive has strengthened its medical writing team with the addition of two new hires. ... Dr Silvana Bardelli (pictured right) joins as a senior medical writer

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    Prior to his new role, Forte has held roles for Bone Therapeutics, TxCell, the European Medicines Agency, and  UCB to name a few.

  • Bone Therapeutics strengthens clinical development team Bone Therapeutics strengthens clinical development team

    His career to date has also seen him hold positions such as vice president, global medical affairs at UCB, as well as senior positions at the European Medicines agency, Bristol-Myers

  • EMA’s head of international affairs steps down EMA’s head of international affairs steps down

    The European Medicines Agency's (EMA) Emer Cooke has resigned as head of international affairs, to be replaced ad interim by Agnès Saint-Raymond. ... She has served as head of international affairs since 2013, and is leaving the agency to pursue a new

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • What does the COVID-19 vaccine mean for the future of R&D? What does the COVID-19 vaccine mean for the future of R&D?

    The European Commission and the UK Government Vaccine Taskforce have also been significant contributors to a wide variety of vaccine projects. ... as the European Medicines Agency (EMA) introduced “rolling reviews”, to monitor data as and when it was

  • Mistrust in medical research: a patient perspective

    She concludes that Thalidomide completely changed the way medicines are tested and approved. ... More public awareness initiatives, such as the European Medicines Agency’s recent public stakeholders meeting on the scientific evaluation of the COVID-19

  • EU Pharmaceutical Strategy Roadmap EU Pharmaceutical Strategy Roadmap

    Orphan Medicinal Products were a major focus. The European Parliament also adopted a resolution in 2017, on possible EU options for improving access to medicines. ... for the European Medicines Agency.

  • Are biobetters a market access opportunity?

    Mircera, used in the treatment of anaemia in Chronic Kidney Disease (CKD), was approved in 2007 by the European Medicines Agency (EMA) for once-monthly dosing as opposed to weekly dosing

  • Why are new medicinal products denied reimbursement in France? Why are new medicinal products denied reimbursement in France?

    This is different to the remit of regulators; while the European Medicines Agency (EMA) conducts a risk/benefit assessment based on efficacy and safety data that takes into consideration the availability ... European Medicines Agency. 2015. Available at:

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics